1: Park SJ, Choi H, Kim JH, Kim CS. Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts. PLoS One. 2021 Mar 25;16(3):e0249041. doi: 10.1371/journal.pone.0249041. PMID: 33765087; PMCID: PMC7993872.
2: Lou Y, Wu J, Liang J, Yang C, Wang K, Wang J, Guo X. Eupatilin protects chondrocytes from apoptosis via activating sestrin2-dependent autophagy. Int Immunopharmacol. 2019 Oct;75:105748. doi: 10.1016/j.intimp.2019.105748. Epub 2019 Jul 12. PMID: 31306979.
3: Cinar AK, Ozal SA, Serttas R, Erdogan S. Eupatilin attenuates TGF-β2-induced proliferation and epithelial-mesenchymal transition of retinal pigment epithelial cells. Cutan Ocul Toxicol. 2021 Jun;40(2):103-114. doi: 10.1080/15569527.2021.1902343. Epub 2021 Apr 8. PMID: 33719768.
4: Lee M, Yang C, Song G, Lim W. Eupatilin Impacts on the Progression of Colon Cancer by Mitochondria Dysfunction and Oxidative Stress. Antioxidants (Basel). 2021 Jun 15;10(6):957. doi: 10.3390/antiox10060957. PMID: 34203665; PMCID: PMC8232173.
5: Wu Z, Zou B, Zhang X, Peng X. Eupatilin regulates proliferation and cell cycle of cervical cancer by regulating hedgehog signalling pathway. Cell Biochem Funct. 2020 Jun;38(4):428-435. doi: 10.1002/cbf.3493. Epub 2020 Jan 11. PMID: 31926121.
6: Sun Y, Ge J, Tang W, Hong H, Liu D, Lin J. Hsa_circ_0045714 induced by eupatilin has a potential to promote fracture healing. Biofactors. 2021 May;47(3):376-385. doi: 10.1002/biof.1707. Epub 2021 Jan 25. PMID: 33496034.
7: Liu H, Hao J, Wu C, Liu G, Wang X, Yu J, Liu Y, Zhao H. Eupatilin Alleviates Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting Inflammation and Oxidative Stress. Med Sci Monit. 2019 Nov 4;25:8289-8296. doi: 10.12659/MSM.917406. PMID: 31680664; PMCID: PMC6854882.
8: Li YY, Wu H, Dong YG, Lin BO, Xu G, Ma YB. Application of eupatilin in the treatment of osteosarcoma. Oncol Lett. 2015 Oct;10(4):2505-2510. doi: 10.3892/ol.2015.3563. Epub 2015 Aug 4. PMID: 26622880; PMCID: PMC4580008.
9: Fei X, Wang J, Chen C, Ding B, Fu X, Chen W, Wang C, Xu R. Eupatilin inhibits glioma proliferation, migration, and invasion by arresting cell cycle at G1/S phase and disrupting the cytoskeletal structure. Cancer Manag Res. 2019 May 24;11:4781-4796. doi: 10.2147/CMAR.S207257. PMID: 31213900; PMCID: PMC6539175.
10: Zhang Y, Qin L, Xie J, Li J, Wang C. Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model. Life Sci. 2020 Jul 15;253:117745. doi: 10.1016/j.lfs.2020.117745. Epub 2020 May 3. PMID: 32376269.
11: Song EH, Chung KS, Kang YM, Lee JH, Lee M, An HJ. Eupatilin suppresses the allergic inflammatory response in vitro and in vivo. Phytomedicine. 2018 Mar 15;42:1-8. doi: 10.1016/j.phymed.2017.08.027. Epub 2017 Sep 21. PMID: 29655675.
12: Zhong W, Wu Z, Chen N, Zhong K, Lin Y, Jiang H, Wan P, Lu S, Yang L, Liu S. Eupatilin Inhibits Renal Cancer Growth by Downregulating MicroRNA-21 through the Activation of YAP1. Biomed Res Int. 2019 Apr 24;2019:5016483. doi: 10.1155/2019/5016483. PMID: 31179326; PMCID: PMC6507163.
13: Li Y, Ren R, Wang L, Peng K. Eupatilin alleviates airway remodeling via regulating phenotype plasticity of airway smooth muscle cells. Biosci Rep. 2020 Jan 31;40(1):BSR20191445. doi: 10.1042/BSR20191445. PMID: 31913462; PMCID: PMC6970064.
14: Lee HY, Nam Y, Choi WS, Kim TW, Lee J, Sohn UD. The hepato-protective effect of eupatilin on an alcoholic liver disease model of rats. Korean J Physiol Pharmacol. 2020 Sep 1;24(5):385-394. doi: 10.4196/kjpp.2020.24.5.385. PMID: 32830145; PMCID: PMC7445478.
15: Lee CJ, Hong SH, Yoon MJ, Lee KA, Choi DH, Kwon H, Ko JJ, Koo HS, Kang YJ. Eupatilin treatment inhibits transforming growth factor beta-induced endometrial fibrosis in vitro. Clin Exp Reprod Med. 2020 Jun;47(2):108-113. doi: 10.5653/cerm.2019.03475. Epub 2020 May 28. PMID: 32460455; PMCID: PMC7315855.
16: Kim J, Kim Y, Yi H, Jung H, Rim YA, Park N, Jung SM, Park SH, Ju JH. Eupatilin ameliorates collagen induced arthritis. J Korean Med Sci. 2015 Mar;30(3):233-9. doi: 10.3346/jkms.2015.30.3.233. Epub 2015 Feb 16. PMID: 25729243; PMCID: PMC4330475.
17: Li F, Tao Y, Qiao Y, Li K, Jiang Y, Cao C, Ren S, Chang X, Wang X, Wang Y, Xie Y, Dong Z, Zhao J, Liu K. Eupatilin inhibits EGF-induced JB6 cell transformation by targeting PI3K. Int J Oncol. 2016 Sep;49(3):1148-54. doi: 10.3892/ijo.2016.3600. Epub 2016 Jul 4. PMID: 27573489.
18: Qiao HB, Li J, Lv LJ, Nie BJ, Lu P, Xue F, Zhang ZM. Eupatilin inhibits microglia activation and attenuates brain injury in intracerebral hemorrhage. Exp Ther Med. 2018 Nov;16(5):4005-4009. doi: 10.3892/etm.2018.6699. Epub 2018 Sep 5. PMID: 30344678; PMCID: PMC6176204.
19: Lee JY, Bae H, Yang C, Park S, Youn BS, Kim HS, Song G, Lim W. Eupatilin Promotes Cell Death by Calcium Influx through ER-Mitochondria Axis with SERPINB11 Inhibition in Epithelial Ovarian Cancer. Cancers (Basel). 2020 Jun 3;12(6):1459. doi: 10.3390/cancers12061459. PMID: 32503295; PMCID: PMC7353024.
20: Park JY, Park DH, Jeon Y, Kim YJ, Lee J, Shin MS, Kang KS, Hwang GS, Kim HY, Yamabe N. Eupatilin inhibits angiogenesis-mediated human hepatocellular metastasis by reducing MMP-2 and VEGF signaling. Bioorg Med Chem Lett. 2018 Oct 15;28(19):3150-3154. doi: 10.1016/j.bmcl.2018.08.034. Epub 2018 Aug 28. Erratum in: Bioorg Med Chem Lett. 2019 Jan 15;29(2):347. PMID: 30177376.